SEC Tracker
Get the app

Possible new VRCA shares

VRCADilution

Known so far: no new shares from the prospectus covers read · shelf room about $9.1M · not yet read: warrants, converts, options, ATM.

Shelf room

  • Room today about $9.1M
  • One third of float $9.1M ($27.3M float, Jun 30, 2025)
  • Sold off it, 12 months nothing
How this is worked out

Shelf room about $9.1M on the S-3 of Dec 15, 2025: the baby-shelf rule (public float under $75M) caps sales at one third of the $27.3M public float stated as of Jun 30, 2025, $9.1M, nothing sold off it in the last 12 months. Sources: S-3 Dec 15, 2025, effective Dec 23, 2025 · public float, as of Jun 30, 2025.

What could become new Verrica Pharmaceuticals (VRCA) shares, from its 10-Q, 10-K, S-3 or 424B filings.

Read so far: the cover share count (17.2M shares, +82% from 9.4M on Aug 5, 2025). Not read yet: warrants, convertible notes, options and RSUs and an ATM program. Read them on EDGAR: the latest 10-Q · S-3 shelf filings.

Shares outstanding

17.2M

Oct 2024 to Jul 2026: from 4.6M to 17.2M. Adjusted for the 1-for-10 reverse split by Aug 5, 2025: each earlier count is divided by the ratio of every split after it.

From the share count on the cover of each 10-Q and 10-K, dated as each cover states.